REFERENCES
1. Patel AR, Lee BH, Campbell SC, Zhou M, Fergany AF. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology 2011;78:1095-9.
2. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010;116:3135-42.
3. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-4.
4. Wang B, Gong H, Zhang X, et al. Bilateral synchronous sporadic renal cell carcinoma: retroperitoneoscopic strategies and intermediate outcomes of 60 patients. PLoS One 2016;11:e0154578.
5. Qi N, Li T, Ning X, Peng X, Cai L, Gong K. Clinicopathologic features and prognosis of sporadic bilateral renal cell carcinoma: a series of 148 cases. Clin Genitourin Cancer 2017;15:618-24.
6. Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes. BJU Int 2007;100:26-9.
7. Jacobs BL, Gibbons EP, Gayed BA, Whetstone JL, Hrebinko RL. Management of bilateral synchronous renal cell carcinoma in a single versus staged procedure. Can J Urol 2009;16:4507-11.
8. Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 2022;82:399-410.
9. Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198:520-9.
10. Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol 2003;169:1276-81.
11. Paterson C, Yew-Fung C, Sweeney C, Szewczyk-Bieda M, Lang S, Nabi G. Predictors of growth kinetics and outcomes in small renal masses (SRM ≤ 4 cm in size): Tayside active surveillance cohort (TASC) study. Eur J Surg Oncol 2017;43:1589-97.
12. Sheikh NA, Khan MH, Pillai S, Lang S, Nabi G. Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a population-based cohort study. Int Urol Nephrol 2018;50:657-63.
13. Campi R, Muselaers S, Bertolo R, et al; EAU Young Academic Urologists (YAU) Renal Cancer Working Group. Selecting the best candidates for non-surgical management of localized renal masses: the Occam’s razor. Minerva Urol Nephrol 2022;74:368-71.
14. Bertolo R, Amparore D, Diana P, et al; EAU Young Academic Urologists (YAU) Renal Cancer working group. Cryoablation of small renal masses in patients with solitary kidneys: worth crossing the road for? Minerva Urol Nephrol 2022;74:794-8.
15. Marchioni M, Amparore D, Ingels A, et al; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. Renal tumors ablation. Minerva Urol Nephrol 2021;73:549-51.
16. Shuch B, Singer EA, Bratslavsky G. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. Urol Clin North Am 2012;39:133-48, v.
17. Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 2019;37:941-6.
18. Steinberg RL, Rasmussen RG, Johnson BA, et al. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol 2021;31:314-24.
19. Wilson MP, Katlariwala P, Murad MH, Abele J, McInnes MDF, Low G. Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis. Abdom Radiol 2020;45:2532-41.
20. Roussel E, Capitanio U, Kutikov A, et al. Novel imaging methods for renal mass characterization: a collaborative review. Eur Urol 2022;81:476-88.
21. Bertolo R, Fiori C, Piramide F, Amparore D, Porpiglia F. The preoperative stratification of patients based on renal scan data is unable to predict the functional outcome after partial nephrectomy. Int Braz J Urol 2018;44:740-9.
22. Porpiglia F, Bertolo R, Amparore D, et al. Evaluation of functional outcomes after laparoscopic partial nephrectomy using renal scintigraphy: clamped vs clampless technique. BJU Int 2015;115:606-12.
23. Pecoraro A, Rosiello G, Luzzago S, et al. Small renal masses with tumor size 0 to 2 cm: a SEER-based study and validation of NCCN guidelines. J Natl Compr Canc Netw 2020;18:1340-7.
24. Rosiello G, Pecoraro A, Luzzago S, et al. Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas. Cancer Causes Control 2021;32:119-26.
25. Pecoraro A, Palumbo C, Knipper S, et al. 710 - Synchronous metastases rates in T1 renal cell carcinoma: a SEER-based study. Eur Urol Open Sci 2020;19:e1087-9.
26. Haas NB, Nathanson KL. Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis 2014;21:81-90.
27. Uzosike AC, Patel HD, Alam R, et al. Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry. J Urol 2018;199:641-8.
28. Mason RJ, Atwell T, Lohse C, et al. Synchronous nephron-sparing approaches for bilateral renal masses: peri-operative and renal functional outcomes. BJU Int 2018;122:243-8.
29. Zhang S, Zhao X, Ji C, et al. Radiofrequency ablation of synchronous bilateral renal cell carcinoma. Int J Urol 2012;19:241-7.
30. Pickersgill NA, Vetter JM, Kim EH, et al. Ten-year experience with percutaneous cryoablation of renal tumors: tumor size predicts disease progression. J Endourol 2020;34:1211-7.
31. Morkos J, Porosnicu Rodriguez KA, Zhou A, et al. Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology 2020;296:452-9.
32. Pecoraro A, Palumbo C, Knipper S, et al. Cryoablation predisposes to higher cancer specific mortality relative to partial nephrectomy in patients with nonmetastatic pT1b kidney cancer. J Urol 2019;202:1120-6.
33. Johnson BA, Sorokin I, Cadeddu JA. Ten-year outcomes of renal tumor radio frequency ablation. J Urol 2019;201:251-8.
34. Trudeau V, Larcher A, Dell’Oglio P, Boehm K, Bishr M, Karakiewicz PI. Local tumour ablation for localized kidney cancer: practice patterns in Canada. Can Urol Assoc J 2015;9:420-3.
35. Seo IY, Rim JS. Bilateral robotic single-site partial nephrectomy. J Laparoendosc Adv Surg Tech A 2011;21:435-8.
36. Hillyer SP, Autorino R, Laydner H, et al. Robotic versus laparoscopic partial nephrectomy for bilateral synchronous kidney tumors: single-institution comparative analysis. Urology 2011;78:808-12.
37. Jung JH, Arkoncel FR, Lee JW, et al. Initial clinical experience of simultaneous robot-assisted bilateral partial nephrectomy and radical prostatectomy. Yonsei Med J 2012;53:236-9.
38. Giberti C, Gallo F, Schenone M, Cortese P. Simultaneous bilateral robotic partial nephrectomy: case report and critical evaluation of the technique. World J Clin Cases 2014;2:224-7.
39. Otoshi T, Yamasaki T, Hirayama Y, Uchida J. Pilot experience of simultaneous robotic-assisted partial nephrectomy for bilateral renal tumors-single center analysis. Asian J Endosc Surg 2021;14:57-62.
40. Di Maida F, Grosso AA, Sforza S, et al. Surgical management of synchronous, bilateral renal masses: a 1-decade referral center experience. Eur Urol Focus 2022;8:1309-17.
41. Cerrato C, Meagher MF, Autorino R, et al. Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group). Minerva Urol Nephrol 2023;75:425-33.
42. Cerrato C, Patel D, Autorino R, et al. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. World J Urol 2023;41:747-55.
43. Mari A, Di Maida F, Tellini R, et al. Oncologic outcomes in patients treated with endoscopic robot assisted simple enucleation (ERASE) for renal cell carcinoma: results from a tertiary referral center. Eur J Surg Oncol 2019;45:1977-82.
44. Minervini A, Campi R, Di Maida F, et al. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma. Urol Oncol 2018;36:527.e1-11.
45. Pandolfo SD, Cerrato C, Wu Z, et al. A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors. Asian J Urol 2023;10:390-406.
46. Pandolfo SD, Wu Z, Campi R, et al. Outcomes and techniques of robotic-assisted partial nephrectomy (RAPN) for renal hilar masses: a comprehensive systematic review. Cancers 2024;16:693.
47. Gallo F, Sforza S, Luciani L, et al. Simultaneous robotic partial nephrectomy for bilateral renal masses. World J Urol 2022;40:1005-10.
48. Gallo F, Sforza S, Mari A, Luciani L, Schenone M, Minervini A. Robotic partial nephrectomy for bilateral renal masses. Curr Urol Rep 2023;24:157-63.
49. Giulioni C, Maggi M, Pirola GM, et al. The current evidence on surgical management for synchronous bilateral renal tumors: results from a scoping review. World J Urol 2023;41:2107-18.
50. Blute ML, Amling CL, Bryant SC, Zincke H. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Mayo Clin Proc 2000;75:1020-6.
51. Klatte T, Ficarra V, Gratzke C, et al. A literature review of renal surgical anatomy and surgical strategies for partial nephrectomy. Eur Urol 2015;68:980-92.
52. Lowrance WT, Yee DS, Maschino AC, et al. Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU Int 2010;105:1093-7.
53. Zaid HB, Parker WP, Lohse CM, et al. Patient factors associated with 30-day complications after partial nephrectomy: a contemporary update. Urol Oncol 2017;35:153.e1-6.
